HSIC
57
6
UNH
57
4
CMCSA
59
2
TXT
60
4
NOC
45
2
MDLZ
53
-4
UAL
67
-2
ISRG
66
-2
SYF
71
4
MO
48
12
CSX
62
5
LH
46
-2
THC
60
-2
FE
56
4
K
62
2
HBAN
47
2
JWN
53
-4
COST
50
-3
QRVO
47
-5
ZBH
53
-3
HSIC
57
6
UNH
57
4
CMCSA
59
2
TXT
60
4
NOC
45
2
MDLZ
53
-4
UAL
67
-2
ISRG
66
-2
SYF
71
4
MO
48
12
CSX
62
5
LH
46
-2
THC
60
-2
FE
56
4
K
62
2
HBAN
47
2
JWN
53
-4
COST
50
-3
QRVO
47
-5
ZBH
53
-3
Financhill
Back

Madrigal Pharmaceuticals Vs. Arcutis Biotherapeutics Industry Stock Comparison

Sell
34

MDGL
Madrigal Pharmaceuticals

Last Price:
212.50
Seasonality Move:
31.83%
Sell
26

ARQT
Arcutis Biotherapeutics

Last Price:
9.37
Seasonality Move:
-16.47%
Sell
34
Madrigal Pharmaceuticals (MDGL) is a Sell

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $212.43. The Score for MDGL is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MDGL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $9.36. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $212.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDGL is experiencing slight selling pressure.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $9.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARQT is experiencing buying pressure, which is a positive indicator for future bullish movement.

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.21 Sell
Relative Strength Index (14 RSI): 30.41 Sell
Chaikin Money Flow: -116852 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (225.37 - 249.29) Sell
Bollinger Bands (100): (227.88 - 277.24) Sell

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 41.78 Sell
Chaikin Money Flow: 1499214 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.76 - 10.82) Sell
Bollinger Bands (100): (8.44 - 10.34) Sell

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 225.04 Sell
20-day SMA: 233.51 Sell
50-day SMA: 250.32 Sell
200-day SMA: 242.64 Sell
8-day EMA: 222.3 Sell
20-day EMA: 232 Sell
50-day EMA: 243.9 Sell
200-day EMA: 238.73 Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.7 Sell
20-day SMA: 10.23 Sell
50-day SMA: 9.8 Sell
200-day SMA: 8.41 Buy
8-day EMA: 9.62 Sell
20-day EMA: 9.91 Sell
50-day EMA: 9.82 Sell
200-day EMA: 8.99 Buy

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.42 per share, an increase next quarter of $3.05 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):